Search Results 251-260 of 17524 for vitiligo

1. Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer - Mayo Clinic

   Patients with well-controlled hyper/hypothyroidism, celiac controlled by diet alone, diverticulosis, diabetes mellitus type I, vitiligo, alopecia, psoriasis ...

2. A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03) - Mayo Clinic

   Skin hypopigmentation (vitiligo). Has history of hypersensitivity to the ... Subjects with eczema, psoriasis, lichen simplex chronicus, or vitiligo ...

3. Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma - Mayo Clinic

   Active known autoimmune disease (except that subjects are permitted to enroll if they have vitiligo; type 1 diabetes mellitus; residual hypothyroidism due ...

4. A Study to Test Nivolumab with Usual Chemotherapy Treatment or Usual Chemotherapy Treatment Alone to Treat Recurrent or Metastatic Nasopharyngeal Cancer - Mayo Clinic

   Note: Patients are permitted to enroll if they have vitiligo; type I diabetes mellitus; hypothyroidism, pituitary or adrenal insufficiency requiring only ...

5. Skin biopsy - Doctors & Departments - Mayo Clinic

   Vitiligo. Show more related content. Products & Services. A Book: Mayo Clinic Family Health Book · Newsletter: Mayo Clinic Health Letter — Digital Edition. Show ...

6. A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease

   Clinically relevant depigmenting or hypopigmenting conditions (e.g. albinism, vitiligo) or active / history of chronic urticaria in the past year.

7. Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas - Mayo Clinic

   Subjects with vitiligo or resolved childhood asthma/atopy would be an exception to this rule. Evidence of interstitial lung disease or active, non ...

8. Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma - Mayo Clinic

   ... vitiligo, type I diabetes mellitus, residual hypothyroidism due to autoimmune condition only requiring hormone replacement, psoriasis not requiring systemic ...

9. MMRC Horizon One Adaptive Platform Trial Evaluating Therapies In RRMM - Mayo Clinic

   Note: Participants with diabetes type 1, vitiligo, psoriasis, or hypo- or hyperthyroid disease not requiring immunosuppressive treatment are eligible

10. Head and neck cancers - Doctors and departments - Mayo Clinic

    ... Vitiligo, Alopecia areata, Melasma, Vascular anomaly, Dermatitis, Morphea, Skin problems, Birthmarks, Vulvar skin disorder, Rosacea, Pigmentation disorder ...